Home › Funds › Daiichi Life Insurance Co., Ltd. › ABBV

Daiichi Life Insurance Co., Ltd. position in ABBV

ABBVIE INC · Health Care

Daiichi Life Insurance Co., Ltd. reported holding 107,919 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$28.2M, representing 0.66% of its reported portfolio and ranking #27 among its reported holdings. Daiichi Life Insurance Co., Ltd. has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)107.92K sh
Reported value held$28.23M
Portfolio Weight0.66%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Daiichi Life Insurance Co., Ltd.'s ABBV position evolved

Daiichi Life Insurance Co., Ltd. first disclosed a stake in ABBV in Q3 2023 at 173,285 shares (US$25.8M). The position peaked in Q4 2025 at 158,149 shares, worth US$36.1M. Across 13 filings, Daiichi Life Insurance Co., Ltd. increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 107,919 shares valued at US$28.2M — a reduction of -5,649 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 173.28K $25.83M New
Q4 2023 172.80K $26.78M Hold
Q1 2024 151.88K $27.66M Reduce
Q2 2024 152.74K $26.20M Add
Q3 2024 140.89K $27.82M Reduce
Q4 2024 140.71K $25.00M Hold
Q1 2025 167.47K $35.09M Add
Q2 2025 150.63K $27.96M Reduce
Q3 2025 132.01K $30.57M Reduce
Q4 2025 158.15K $36.14M Add
Q1 2026 139.20K $30.27M Reduce
Q2 2026 113.57K $28.58M Reduce
Q3 2026 107.92K $28.23M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Daiichi Life Insurance Co., Ltd. held ABBV?

Daiichi Life Insurance Co., Ltd. has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Daiichi Life Insurance Co., Ltd.'s current position in ABBV?

As of Q3 2026, Daiichi Life Insurance Co., Ltd. holds 107.92K shares of ABBV (ABBVIE INC), valued at $28.23M, representing 0.66% of its reported portfolio and ranking #27.

Has Daiichi Life Insurance Co., Ltd. been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Daiichi Life Insurance Co., Ltd. reduced its position in ABBV. The position peaked in Q4 2025 at 158.15K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.